 |
|
| Blog results | Results 1 - 10 of about 17,956 for acute myloid leukemia. (0.17 seconds) |
| Sorted by relevance Sort by date |
| Related Blogs: | Almost Shaved My Head - http://almostshavedmyhead.blogspot.com/ Leukemia - http://community.livejournal.com/lukemeia OPERATION PURPLE HEART - http://operationpurpleheart.blogspot.com/ | |
| 28 minutes ago by MaverickNY Acute myeloid leukemia (AML) is a truly nasty disease and one I hope never to have the misfortune to be diagnosed with. Last month, at the Chemotherapy Foundation in New York, Dr Norman Wolmark gave an entertaining lecture on what... Pharma Strategy Blog - http://www.pharmastrategyblog.com/ |
| 12 Dec 2009 by DrugsNews Sunesis Completes Enrollment Of Voreloxin REVEAL-1 Trial In Acute Myeloid Leukemia; Lorus Therapeutics Announces Positive Result in Its Phase II Clinical Study of LOR-2040 in Acute Myeloid Leukemia (AML); Cyclacel Reports Phase 2 ... Drugs Reviews | Dugs News - http://www.drugs-review.com/ |
| 1 hour ago by Mike (Beetle) Bailey "It can't all be coincidence," said one of the site's members, JoAnne Och, whose son Steven is one of several people named on the site who died of Acute myeloid leukemia shortly after returning from Balad. "For one thing, you don't send ... Military & Veterans: Politics for the deserving - http://vets4politics.blogspot.com/ |
| 10 hours ago by Business Wire The Company's lead product is Ceplene, which has been granted full marketing authorization by the European Commission for the remission maintenance and prevention of relapse in adult patients with Acute Myeloid Leukemia (AML) in first ... Your Story - http://www.your-story.org/ |
| 3 hours ago Sapacitabine, a cell cycle modulating nucleoside analog, is in Phase 2 studies for the treatment of acute myeloid leukemia in the elderly, myelodysplastic syndromes, advanced CTCL and lung cancer and in Phase 1 in combination with ... GlobeNewswire: Pharmaceuticals News - http://www.globenewswire.com/newsroom/?kw=PHARMACEUTICALS |
| 11 Dec 2009 by Pat Killingsworth Also at ASH, a phase II study from Washington University showed REVLIMID also has an important benefit in a related condition, acute myeloid leukemia (AML), a difficult-to-treat form of leukemia that often develops from MDS. ... HelpWithCancer.Org - http://www.helpwithcancer.org/ |
| 5 Dec 2009 (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") announced today 1-year survival data from a Phase 2 randomized trial of oral sapacitabine capsules, a novel nucleoside analogue, in elderly patients with acute myeloid leukemia ... GlobeNewswire: Health News - http://www.globenewswire.com/newsroom/?kw=HEALTH |
| 1 hour ago by Wendy Diller FDA complete response letter requests another randomized study of the acute myeloid leukemia drug to show it is safe and increases survival in elderly patients. read more · Cubist Hopes For A Blockbuster Antibiotic With In Acquisition ... BioPharma Today - http://www.biopharmatoday.com/ |
| 5 Dec 2009 by worldmarketnews Cyclacel Reports Phase 2 Sapacitabine Data in Acute Myeloid Leukemia and Myelodysplastic Syndromes at 2009 ASH .. http://bit.ly/90MDi0. worldmarketnews timeline - http://identi.ca/worldmarketnews |
| 7 Dec 2009 - Planning underway for a pivotal trial to start in 2010 - - Conference call scheduled for Monday December 7th at 9:30 AM Eastern - Berkeley Heights, NJ, December 5, 2009 – Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ:... Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
